Le Lézard
Classified in: Health, Sports and recreation
Subject: NPT

Super Bowl Champion Willie Colon Drives 10th Anniversary Lupus Research Alliance Golf Fundraiser

SUMMIT, N.J., June 24, 2024 /PRNewswire/ -- The Lupus Research Alliance is proud to partner with former Pittsburgh Steelers and New York Jets player, Super Bowl Champion, and current FoxSport1 co-host Willie Colon on the 10th Annual Willie Colon Golf Outing crafted by Tito's Handmade Vodka.

The sold-out outing is anticipated to raise $450,000 in honor of Mr. Colon's late mother Jean Davis, who had lupus. On the 10th Anniversary of this event, it has raised $2,370,488 and counting.

Mr. Colon is being joined by sports superstars and nearly 300 golfers to take shots at this challenging disease. Colleagues at the event include Craig Carton and David Jacoby from the Carton Show (FS1). Former NFL players in attendance include Justin Tuck (New York Giants); David Harris (New York Jets); Mike Adams (Carolina Panthers); Brian Winters (New York Jets); Matt Simms (New York Jets); Erik Coleman (New York Jets); Barrett Brooks (Philadelphia Eagles); Trai Essex (Pittsburgh Steelers); Darnell Stapleton (Pittsburgh Steelers); and Adalius Thomas (Baltimore Ravens).

"We first teamed up with the Lupus Research Alliance ten years ago to host this event because we knew funding research is the best way we can make a difference," commented Colon. "My mom so appreciated seeing all our friends and teammates show up at this golf outing in her honor. I know she would be thrilled to know we have already raised well over $2.3 million and still going strong."

Colon conveyed his appreciation to the six chairs who helped organize the highly successful outing: Xavier V. Goss, at Capital Group; Ted Knauss, at The PNC Financial Services Group; Daniel LaVecchia at BGC Partners, Inc.; Nidhi Patel at BlackRock and Julius D. Williams at Invesco. Thanks also went to primary sponsors: Tito's Handmade Vodka, Tunnel To Towers Foundation, Willie & Aikisha Colon Foundation, and Corona & Constellation Brands.

As a long-time and active member of the LRA Board of Directors, Colon is proud that 100% of every dollar raised goes to enabling the world's top scientists to pursue innovative research studies like the grant named for his mom.

About Lupus
Lupus is a chronic, complex autoimmune disease that affects millions of people worldwide. More than 90 percent of people with lupus are women, often striking during the childbearing years of 15-45. Black, Hispanic, Indigenous, and Asian/Pacific Islander people are disproportionately affected by lupus and are more likely to experience severe lupus symptoms. In lupus, the immune system, meant to defend against infections, produces antibodies that mistakenly recognize the body's own cells as foreign, prompting other immune cells to attack and potentially damage organs such as the kidneys, brain, heart, lungs, blood, skin, and joints.

About the Lupus Research Alliance
The Lupus Research Alliance is the largest non-governmental, non-profit funder of lupus research worldwide. The organization aims to transform treatment by funding the most innovative lupus research, fostering diverse scientific talent, and driving discovery toward better diagnostics, improved treatments and ultimately a cure for lupus. Because the Lupus Research Alliance's Board of Directors funds all administrative and fundraising costs, 100% of all donations goes to support lupus research programs. For more information, please visit the LRA at LupusResearch.org and on social media at: XFacebook, LinkedIn, and Instagram.

SOURCE Lupus Research Alliance

These press releases may also interest you

at 04:23
Biosyngen, a leading biotechnology company focused on the development of innovative cell therapies, recently announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) in China has approved the...

at 04:05
Azafaros B.V. today announced positive topline data from its RAINBOW study, a Phase 2 clinical trial investigating nizubaglustat in patients with a genetic diagnosis of either GM2 gangliosidosis or Niemann-Pick disease type C (NPC). About the Trial...

at 03:30
EQT Life Sciences is pleased to share that the LSP Dementia Fund...

at 03:05
CULT Food Science Corp. ("CULT" or the "Company") (FRA: LN00), a disruptive food technology platform pioneering the commercialization of lab grown meat and cellular agriculture to reshape the global food industry, congratulates venture arm company,...

at 03:00
Novo Holdings, a leading life science investor, today announces it led a...

at 03:00
Financing led by Novo Holdings, including new investment from EQT Life Sciences ? LSP Dementia Fund, OrbiMed and SR One with participation from existing investors M Ventures, Sofinnova Partners, GSK Equities Investments Limited and Johnson & Johnson...

News published on and distributed by: